KMKarla Morganna Pereira Pinto de Mendonça

Karla Morganna Pereira Pinto de Mendonça

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karla Morganna Pereira Pinto de Mendonça has a total of 132 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Portuguese Version of the PROMIS® Self‐Efficacy for Managing Daily Activities for Patients With Chronic Conditions: Translation and Cross‐Cultural Adaptation

    by Sarah Joysi Almeida Leite, Thayla Amorim Santino, Sara Ahmed, João Carlos Alchieri, Joubert Barbosa, Karolinne Souza Monteiro, Karla Mendonça

    Purpose: To translate and cross‐culturally adapt the PROMIS® Self‐Efficacy for Managing Daily Activities for Portuguese‐speaking populations, ensuring linguistic and conceptual equivalence for future validation, while considering differences between Brazil and Portugal. Methods: The Functional Assessment of Chronic Illness Therapy (FACIT) methodology was followed, including (1) independent translations by Brazilian and Portuguese native speakers; (2) reconciliation into a single version; (3) back‐translation; (4) expert review; (5) cognitive debriefing with participants from both countries and (6) final approval by the PROMIS® Statistical Center. Ethical approval was obtained from the Federal University of Rio Grande do Norte. Results: Minimal linguistic and cultural differences were found between Brazilian and European Portuguese. Vocabulary adjustments were made to ensure clarity (e.g., “tela” vs. “écrã,” “celular” vs. “telemóvel”). The cognitive debriefing involved seven participants (four from Brazil and three from Portugal). A new response option was added for individuals with mobility impairments. The final version preserved the scale's psychometric integrity while ensuring cultural relevance. Conclusion: The adapted Portuguese version of the PROMIS® Self‐Efficacy for Managing Daily Activities maintains its conceptual fidelity and usability across Portuguese‐speaking populations. The item bank is ready for validation studies and clinical use in Lusophone healthcare settings.

  • Asma: o que você precisa saber?

    by Brenda Morganna Mendonça de Souza, Karla Morganna Pereira Pinto de Mendonça

    Asma é uma doença crônica caracterizada pela inflamação das vias aéreas, ou seja, dos tubos que transportam o ar para dentro e para fora dos pulmões.

  • Medicamentos para controle e alívio rápido: existe diferença?

    by Karla Morganna Pereira Pinto de Mendonça, Thayla Amorim Santino, Gyovanna Larissa Barbosa da Silva

    Estes são grupos de medicamentos que têm o objetivo de reduzir a inflamação, controlar os sintomas da asma e reduzir o risco de ocorrência de novas crises. O tratamento de manutenção também previnem a diminuição da função dos pulmões e os efeitos indesejáveis de medicamentos, como exemplo citamos os corticoides de uso oral.

  • Pediatric Asthma Therapy Assessment Questionnaire for the Brazilian population: Cross‐cultural adaptation and measurement properties

    by Thayla Amorim Santino, Hesli de Sousa Holanda, Juliana Cirilo Soares de Souza, Maria Clara Almeida Jácome, Fernanda Elizabeth Pereira da Silva Menescal, Joubert Vitor de Souto Barbosa, Ada Cristina Jácome, Cleia Teixeira Do Amaral, João Carlos Alchieri, Karla Morganna Pereira Pinto de Mendonça

    Objective: To cross‐culturally adapt the Pediatric Asthma Therapy Assessment Questionnaire (ATAQ) into Brazilian Portuguese and analyze its measurement properties.Methods: This exploratory methodological study included eight experts and 30 caregivers in the translation and cross‐cultural adaptation steps. Thereafter, 118 caregivers of pediatric patients with asthma aged between 5 and 17 years were involved in the analysis of measurement properties. We analyzed the content, structural (exploratory and confirmatory factorial), construct (convergent and discriminant), and known‐groups validities; floor and ceiling effects; and determined the cut‐off point (receiver operator characteristic curve) to identify pediatric patients with uncontrolled asthma. Intraclass correlation coefficient (ICC) analyzed test−retest reliability with 54 caregivers, whereas Cronbach's α and composite reliability verified the internal consistency of the items.Results: The committee of experts and caregivers found the instructions and response options relevant, understandable, and clear (K > 0.75). During the cross‐cultural adaptation, three items (2, 4, and 12) were slightly modified by including terms to facilitate understanding. A two‐factor structure (asthma control and patient‐provider communication) was identified. Internal consistency (α > .67; composite reliability > 0.73) and test−retest reliability (ICC > 0.80) were acceptable. For construct and know‐groups validities, 85.71% of the hypothesis were confirmed. A cut‐off point of >3 for the control domain was considered adequate to identify pediatric patients with uncontrolled asthma (sensitivity: 86.21%; specificity: 80.90%).Conclusion: The Pediatric ATAQ was adequately adapted for Brazilian pediatric patients with asthma and produced valid and reliable measures for assessing asthma control. Therefore, it may be considered an adequate instrument for monitoring asthma control in the Brazilian pediatric population.


  • Open Access

    Psychometric properties of the Brazilian Pediatric Asthma Control and Communication Instrument - electronic version

    by Hesli de Sousa Holanda, Thayla Santino, Maria Clara Almeida Jácome, Juliana Cirilo Soares de Souza, Joubert Vitor de Souto Barbosa, Sande Okelo, Cecilia Patino, Clea Do Amaral, João Alchieri, Karla Mpp Mendonça

    Introduction: Validated instruments assess asthma control, improving its management. Most are available only in electronic versions, which may limit the assessment of children who live far from reference centers. Nevertheless, electronic instruments for assessing asthma control in the Brazilian population are scarce. Objective: To assess the psychometric properties of the electronic version of the Pediatric Asthma Control and Communication Instrument (e-PACCI). Methods: This exploratory psychometric study included caregivers of children or adolescents diagnosed with asthma. Those who dropped out or had difficulties understanding and communicating were excluded. A two-week interval was adopted between the standard interview and e-PACCI assessments. Results: A total of 62 individuals were included in the study; 95.1% were women. The e-PACCI presented good internal consistency (Cronbach’s α = 0.84) and agreement (ICC = 0.87; CI = 0.81 to 0.91; p < 0.001). The t-test demonstrated equality between versions (p = 0.94). The criterion validity for the asthma control domain presented a moderate correlation between versions (r = 0.52; p = 0.01), and the Spearman test correlated the Pediatric Quality of Life Inventory with the asthma control domain of the e-PACCI for construct validity. The asthma symptoms and treatment problems domains presented moderate (r = 0.63; p < 0.001) and weak correlations (r = 0.28; p = 0.02), respectively. In addition, the worry and communication domains did not correlate. Conclusion: The e-PACCI demonstrated reliable and valid psychometric properties.

  • Open Access

    Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis

    by Tácito Zaildo, Thayla Amorim Santino, Gabriela Chaves, Baldomero Antonio Kato da Silva, João Carlos Alchieri, Cecilia M. Patino, Sarah Leite, Kleber Giovanni Luz, Ricardo Oliveira Guerra, Tito Hugo Soares da Penha, et al.

    Aims: To summarise the evidence on barriers to and facilitators of population adherence to prevention and control measures for coronavirus disease 2019 (COVID-19) and other respiratory infectious diseases.Methods: A qualitative synthesis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis and the Cochrane Effective Practice and Organization of Care: Qualitative Evidence Synthesis. We performed an electronic search on MEDLINE, Embase and PsycINFO from their inception to March 2023.Results: We included 71 studies regarding COVID-19, pneumonia, tuberculosis, influenza, pertussis and H1N1, representing 5966 participants. The measures reported were vaccinations, physical distancing, stay-at-home policy, quarantine, self-isolation, facemasks, hand hygiene, contact investigation, lockdown, infection prevention and control guidelines, and treatment. Tuberculosis-related measures were access to care, diagnosis and treatment completion. Analysis of the included studies yielded 37 barriers and 23 facilitators.Conclusions: This review suggests that financial and social support, assertive communication, trust in political authorities and greater regulation of social media enhance adherence to prevention and control measures for COVID-19 and infectious respiratory diseases. Designing and implementing effective educational public health interventions targeting the findings of barriers and facilitators highlighted in this review are key to reducing the impact of infectious respiratory diseases at the population level.


  • Open Access

    Effects of home healthcare for adults with chronic respiratory diseases and post-COVID-19 syndrome on hospital bed turnover rate: a protocol of systematic review with meta-analysis

    by Sarah Leite, Karolinne Souza Monteiro, Thayla Amorim Santino, Gabriela Chaves, Joubert Vitor de Souto Barbosa, Tácito Z M Santos, Cleia Amaral, Sara Ahmed, Zenewton André da Silva Gama, Karla Morganna Pereira Pinto de Mendonça

    Introduction Chronic respiratory diseases (CRDs) have a high prevalence, morbidity and mortality worldwide. After the COVID-19 pandemic, the number of patients readmitted after hospital discharge increased. For some populations, early hospital discharge and home healthcare may reduce health costs in patients treated at home when compared with those hospitalised. This study aims to systematically review the effectiveness of home healthcare for patients with CRDs and post-COVID-19 syndrome. Methods and analysis We will search on MEDLINE, CENTRAL, Embase and PsycINFO. We will include randomised controlled trials (RCTs) and non-RCT studies reported in full text and abstracts. No language restriction will be applied. We will include studies related to adults with a diagnosis of CRDs or post-COVID-19 syndrome that compared in-patient hospital care with any home healthcare. We will exclude studies with participants with neurological, mental diseases, cancer or pregnant women. Two review authors will screen abstracts and select the eligible studies. To investigate the risk of bias, we will use the Cochrane ‘Risk of Bias’ tool for RCT, and the Risk of Bias In Non-randomised Studies-of Interventions for non-RCT. We will use the five Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) considerations to assess the quality of the evidence. Patients and the public will be involved in the preparation, execution and implementation phases of the review. Ethics and dissemination No ethical approval is required because only published data will be analysed. The publication of the results in peer-reviewed journals and at relevant conferences will guide the direction of future research in the field and healthcare practice. The results will also be disseminated in plain language on social media to disseminate the knowledge to society and the public interested in the topic.


  • Open Access

    Buteyko method for people with asthma: a protocol for a systematic review and meta-analysis

    by Karla Morganna Pereira Pinto de Mendonça, Sean Collins, Tácito Zm Santos, Gabriela Chaves, Sarah Leite, Thayla Amorim Santino, Karolinne Souza Monteiro

    Introduction Buteyko method is recommended as a non-pharmacological treatment for people with asthma. Although the worldwide interest in the Buteyko method, there is a paucity of studies gathering evidence to support its use. Therefore, we aim to conduct a systematic review and meta-analysis to assess the effects of the Buteyko method in children and adults with asthma. Methods and analysis We will search on Cochrane Central Register of Controlled Trials, MEDLINE, Embase, US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov and WHO International Clinical Trials Registry Platform for studies focusing on the Buteyko method for children and adults with asthma. The searches will be carried out in September 2021 from database’s inception to the present. We will include randomised controlled trials comparing Buteyko method alone with asthma education or inactive control intervention. There will be no restriction on language. Primary outcomes include quality of life, asthma symptoms and adverse events/side effects. Two review authors will independently screen the studies for inclusion and extract data. We will assess the quality of the included studies using the ‘Risk of Bias’ tool. The certainty of the evidence will be assessed using the GRADE approach. Data synthesis will be conducted using Review Manager software. Reporting of the review will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidance and the Cochrane Handbook for Systematic Reviews of Interventions. Ethics and dissemination This study will assess and provide evidence for the use of the Buteyko method in people with asthma. We will analyse secondary data and this does not require ethics approval. The findings will be published in peer-reviewed journals, at relevant conferences and will be shared in plain language in social media. Moreover, the findings of this review could guide the direction of healthcare practice and research. PROSPERO registration number CRD42020193132.


  • Open Access

    Barriers and facilitators to populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a rapid qualitative evidence synthesis protocol

    by Karolinne Souza Monteiro, Thayla Amorim Santino, Ada Cristina Jácome, Baldomero Silva, Cecilia M Patino, Gabriela Chaves, João Carlos Alchieri, Sarah Leite, Kleber Giovanni Luz, Ricardo O Guerra, et al.

    Introduction The current COVID-19 pandemic has increased the need for populational adherence to measures for the prevention and control of respiratory infectious diseases. However, their effectiveness depends on the population’s preventive behaviour, which may be divergent from public policies. Therefore, this study aims to summarise and evaluate the evidence on barriers and facilitators to populational adherence to prevention and control measures in COVID-19 and other respiratory infectious diseases. Methods and analysis We will search on MEDLINE, Embase and PsycINFO for studies focusing on adults receiving protective behaviour recommendations to combat COVID-19 and other respiratory infectious diseases. The searches will be carried out from database’s inception to the present. We will include studies that use qualitative methods in their data collection and analysis and studies that use mixed methods if they include any qualitative methods of analysis. Studies published in English, Portuguese and Spanish will be included. Two review authors will independently screen the studies for inclusion and extract data. We will assess the quality of the included studies using the Critical Skills Appraisal Programme tool. For the assessment of the confidence in the synthesised findings, we will use the GRADE-Confidence in the Evidence from Reviews of Qualitative research. Data analysis will be conducted using the best-fit framework approach based on adapted dimensions from the Health Belief Model and the Behaviour Change Wheel. Ethics and dissemination This study will be conducted on published evidence, and thus, no ethical approval is required. The findings of this rapid qualitative evidence synthesis will be disseminated to academic audiences, health policy-makers and the general population. We will publish the results in peer-reviewed journals, present our findings in conferences, and disseminate results via social media. We also aim to present the research findings in plain language and disseminate the knowledge to the general population to increase public interest. PROSPERO registration number CRD42020205750.


  • Psychometric evaluation of the Brazilian version of the pediatric asthma control and communication instrument

    by Thayla Amorim Santino, Raquel Emanuele de França Mendes Alves, Karolinne Souza Monteiro, Sande O. Okelo, Cecília M. Patino, João Carlos Alchieri, Karla Morganna P. P. Mendonça

    Background: There is a lack of questionnaires capable of evaluating the clinical control of Brazilian children and adolescents with asthma over a wide age range. The Pediatric Asthma Control and Communication Instrument (PACCI) has been validated, but only with English‐ and Spanish‐speaking children in the United States.Objectives: To evaluate the psychometric properties of the Brazilian version of the PACCI questionnaire.Methods: A cross‐sectional psychometric study conducted with children and adolescents aged 01 to 19 years with a clinical diagnosis of asthma, and their respective parents/guardians. The following assessments were conducted: socioeconomic status; clinical control using the Childhood Asthma Control Test (c‐ACT), Asthma Control Test (ACT); caregiver quality of life using the Pediatric Asthma Caregivers Quality of Life Questionnaire (PACQLQ); and pulmonary function test (spirometry). Validity was evaluated as follows: exploratory and confirmatory factor analysis; Cronbach's alpha analysis (α); floor and ceiling effects; receiver operator characteristic curve analysis.Results: A total of 128 participants were included, most of them male (54.7%). The Brazilian version of PACCI had adequate internal consistency (α = .76) and moderate floor and ceiling effects. The internal structure presented acceptable adjustment indices, considering the extraction of four factors. The factors presented adequate α values. Asthma control factor 1 correlated with c‐ACT/ACT and PACQLQ. Control domain scores greater than four points (sum of score) and above 1 point (problem index) were indicative of uncontrolled asthma.Conclusion: The Brazilian version of PACCI was able to provide valid and reliable measures in evaluating the clinical control of asthma in Brazilian children and adolescents.